EEGEE

EEGEE

2/1/2025, 1:16:40 PM

https://www.linkedin.com/posts/vivek-singh-48b701121_stressinindianoffices-indianofficelife-workstressindia-activity-7290773353957629952-txx3?utm_source=social_share_send&utm_medium=android_app&utm_campaign=copy_link

EEGEE

2/1/2025, 1:17:04 PM

https://www.linkedin.com/posts/vivek-singh-48b701121_employeerecognition-talentdevelopment-leadership-activity-7290240984448167936-XsuT?utm_source=social_share_send&utm_medium=android_app&utm_campaign=copy_link

EEGEE

2/1/2025, 4:42:28 PM

https://www.linkedin.com/posts/vivek-singh-48b701121_spain-visitspain-spaintourism-activity-7291495941549821953-w3xh?utm_source=social_share_send&utm_medium=android_app&utm_campaign=copy_link

EEGEE

2/3/2025, 8:23:20 AM

https://www.linkedin.com/posts/vivek-singh-48b701121_badleadership-toxicleadership-poormanagement-activity-7292093035503390721-uTvC?utm_source=social_share_send&utm_medium=android_app&utm_campaign=copy_link

EEGEE

2/21/2025, 5:14:37 AM

Top 10 pharmaceutical companies in India: #1. Sun Pharmaceutical Industries Ltd. - _Revenue:_ ₹32,444 crores (2022) - _Market Cap:_ ₹2,43,931 crores (2022) - _Products:_ Specialty generics, APIs, and formulations #2. Cipla Ltd. - _Revenue:_ ₹19,758 crores (2022) - _Market Cap:_ ₹54,611 crores (2022) - _Products:_ Respiratory, cardiovascular, and anti-infective medicines #3. Dr. Reddy's Laboratories Ltd. - _Revenue:_ ₹18,972 crores (2022) - _Market Cap:_ ₹53,339 crores (2022) - _Products:_ Generics, biosimilars, and proprietary products #4. Lupin Ltd. - _Revenue:_ ₹17,791 crores (2022) - _Market Cap:_ ₹41,433 crores (2022) - _Products:_ Cardiovascular, diabetes, and respiratory medicines #5. Aurobindo Pharma Ltd. - _Revenue:_ ₹23,287 crores (2022) - _Market Cap:_ ₹38,111 crores (2022) - _Products:_ Generics, APIs, and formulations #6. Torrent Pharmaceuticals Ltd. - _Revenue:_ ₹8,358 crores (2022) - _Market Cap:_ ₹52,611 crores (2022) - _Products:_ Cardiovascular, diabetes, and gastrointestinal medicines #7. GlaxoSmithKline Pharmaceuticals Ltd. - _Revenue:_ ₹3,254 crores (2022) - _Market Cap:_ ₹25,119 crores (2022) - _Products:_ Respiratory, anti-infective, and dermatology medicines #8. Zydus Cadila - _Revenue:_ ₹14,926 crores (2022) - _Market Cap:_ ₹53,452 crores (2022) - _Products:_ Generics, biosimilars, and proprietary products #9. Pfizer Ltd. - _Revenue:_ ₹2,154 crores (2022) - _Market Cap:_ ₹18,441 crores (2022) - _Products:_ Cardiovascular, anti-infective, and oncology medicines #10. Sanofi India Ltd. - _Revenue:_ ₹3,364 crores (2022) - _Market Cap:_ ₹15,119 crores (2022) - _Products:_ Diabetes, cardiovascular, and anti-infective medicines